Blog
Wall Street Analysts Think Adeia (ADEA) Could Surge 27.58%: Read This Before Placing a Bet
Adeia (ADEA) closed the last trading session at $15.48, gaining 19.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Think Alkami (ALKT) Could Surge 50.64%: Read This Before Placing a Bet
Shares of Alkami Technology (ALKT) have gained 15.3% over the past four weeks to close the last trading session at $25.69, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?
Shares of Anika Therapeutics (ANIK) have gained 11.8% over the past four weeks to close the last trading session at $9.23, but there could still be a solid upside left in the stock if short-term
After Golden Cross, Element Solutions (ESI)'s Technical Outlook is Bright
After reaching an important support level, Element Solutions Inc. (ESI) could be a good stock pick from a technical perspective. ESI recently experienced a "golden cross" event, which saw its 50-day
How Much Upside is Left in Globale Online (GLBE)? Wall Street Analysts Think 36.83%
Shares of Global-e Online Ltd. (GLBE) have gained 3.1% over the past four weeks to close the last trading session at $34.18, but there could still be a solid upside left in the stock if short-term
How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79%
Shares of Inventiva S.A. Sponsored ADR (IVA) have gained 89.8% over the past four weeks to close the last trading session at $6.35, but there could still be a solid upside left in the stock if
Wall Street Analysts See an 115.23% Upside in Xperi (XPER): Can the Stock Really Move This High?
Xperi (XPER) closed the last trading session at $6.04, gaining 0.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
T. Rowe Price (TROW)'s Technical Outlook is Bright After Key Golden Cross
T. Rowe Price Group, Inc. (TROW) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TROW's 50-day simple moving average broke out
Wall Street Analysts Predict a 33.1% Upside in Potbelly (PBPB): Here's What You Should Know
Shares of Potbelly (PBPB) have gained 8.2% over the past four weeks to close the last trading session at $13.02, but there could still be a solid upside left in the stock if short-term price targets
Spruce Biosciences (SPRBD) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
The price trend for Spruce Biosciences, Inc. (SPRBD) has been bearish lately and the stock has lost 11.8% over the past week. However, the formation of a hammer chart pattern in its last trading
Should You Buy Pediatrix Medical Group (MD) After Golden Cross?
After reaching an important support level, Pediatrix Medical Group, Inc. (MD) could be a good stock pick from a technical perspective. MD recently experienced a "golden cross" event, which saw its
Here's Why Investors Should Bet on Wabtec Stock Right Now
Westinghouse Air Brake Technologies’ WAB, operating as Wabtec Corp, top line is benefiting from robust backlog growth, boosting the company’s performance. Moreover, shareholder-friendly initiatives
Why Tyson Foods (TSN) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
PRA Group (PRAA) is a Top-Ranked Momentum Stock: Should You Buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Donaldson (DCI) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Why Broadridge Financial Solutions (BR) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Here's Why Annaly Capital Management (NLY) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Keysight (KEYS) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Phibro Animal Health (PAHC) is a Top-Ranked Momentum Stock: Should You Buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Why Ericsson (ERIC) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now?
Investors are showing growing interest in the rapidly expanding structural heart device market, which is expected to witness a compound annual growth rate (CAGR) of 13.5% between 2025 and 2033,
EQT Signs Long-Term Deal With Sempra for the Purchase of LNG
EQT Corporation EQT, a leading natural gas production company, signed an agreement with Sempra, a U.S.-based energy company, for the purchase of 2 million tons per annum (mtpa) of liquefied natural